Cargando…
Coronavirus disease 2019 vaccine administration in patients with reported reactions to polyethylene glycol- and polysorbate-containing therapeutics
BACKGROUND: Polyethylene glycol (PEG) and polysorbate reactions were initially implicated as a likely risk factor for reacting to coronavirus disease 2019 (COVID-19) vaccines and remain a source of vaccine hesitancy despite increasing evidence that they do not pose an increased risk for COVID-19 vac...
Autores principales: | Otani, Iris M., Tsao, Lulu R., Tang, Monica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American College of Allergy, Asthma & Immunology. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8916834/ https://www.ncbi.nlm.nih.gov/pubmed/35288274 http://dx.doi.org/10.1016/j.anai.2022.03.006 |
Ejemplares similares
-
COVID-19 Vaccination in Patients with Documented Reactions to Polyethylene Glycol or Polysorbate
por: Tang, Monica, et al.
Publicado: (2022) -
Polyethylene glycol and polysorbate testing in 12 patients before or after coronavirus disease 2019 vaccine administration
por: Carpenter, Taya, et al.
Publicado: (2022) -
Polyethylene glycol and polysorbate skin testing in the evaluation of coronavirus disease 2019 vaccine reactions: Early report
por: Pitlick, Mitchell M., et al.
Publicado: (2021) -
Tolerability of polysorbate 80–containing COVID-19 vaccines in confirmed polyethylene glycol–allergic patients
por: Ieven, Toon, et al.
Publicado: (2021) -
Endotyping of IgE-mediated polyethylene glycol and/or polysorbate 80 allergy.
por: Ieven, Toon, et al.
Publicado: (2023)